Seeking Alpha

ISIS
  Isis Pharmaceuticals, Inc. - NASDAQ

10/21/2014, 9:39 PM ET
  • jimmy Turano | Send Message 10 Sep 2009

    ISIS makes strides in RNAI-OLD in todays news. RE:MRNA MRNA NEEDS TO REVERSE SPLIT THE STOCK & MANAGEMENT SHOULD BUY MORE STOCK&INCREASE THEIR %
    Reply
      ISIS vs. ETF Alternatives
      Company Description
      Isis Pharmaceuticals is engaged in antisense drug discovery and development, exploiting a novel drug discovery platform it created to generate a broad pipeline of first-in-class drugs.